Now I have all the information I need. Let me compose the final review.

## Summary

This paper proposes a conformalized procedure for constructing lower prediction bounds (LPBs) for counterfactual survival times under general right-censoring. The key technical contribution is a reweighting scheme (equation 1) that transforms the coverage probability for counterfactual outcomes into a weighted conformal inference problem over uncensored, treated observations, enabling the application of weighted conformal prediction (Lei & Candes, 2021). The paper claims to provide "exact marginal coverage" guarantees, overcoming the PAC-type guarantees of prior work (Gui et al., 2024; Davidov et al., 2025), and further claims a "doubly robust" property.

## Strengths

- **The reweighting scheme in equation (1) is a genuine and non-trivial insight.** The derivation from step (i) through (iv), particularly the inequality at step (iii) that exploits the stochastic ordering induced by conditioning on uncensored observations (T⊥C|X ⟹ T|e=1,X ≼_st T|X), enabling the upper bound to equal exactly α, is technically sound and creative. This transforms counterfactual censored prediction into a tractable weighted conformal inference problem.

- **The marginal vs. PAC-type guarantee distinction is meaningful for clinical applications.** Even with the estimation error term, marginal coverage provides a different type of guarantee than PAC-type: it averages over the entire population including extreme cases, rather than providing a high-probability guarantee conditional on the calibration data. Figure 3 demonstrates that under outlier contamination, PAC-type methods can fail to maintain coverage while the proposed method remains stable—empirically validating the practical advantage of this distinction.

- **Comprehensive simulation design** with six settings varying censoring rates (20%–80%) and treatment proportions, plus outlier robustness checks (Figure 3), sensitivity analyses on the weight function and regression algorithm (Appendix E.4–E.5), and multi-treatment extensions (Figure 2).

- **Clinically relevant real data application** on a 541-patient NSCLC dataset where LPBs align with known prognostic factors (VMAT vs. IMRT consistent with Hunte et al. 2022; chemotherapy regimens consistent with Curran et al.; Aguado et al. 2022), demonstrating practical applicability.

- **Algorithm 1 is clearly presented and implementable**, with well-defined steps for data splitting, non-conformity scoring, weight computation, and quantile-based calibration.

## Weaknesses

### Fatal
None.

### Major

- **The "exact marginal coverage" claim is overstated and the paper's central framing is misleading.** The abstract states "exact miscoverage guarantee," the introduction promises "exact marginally valid LPB," and Section 3 says the method "can achieve exact marginal coverage." Yet the paper's own main result, Theorem 4.1 (Eq. 4), shows: P(T^(w) ≥ L̂) ≥ 1 − α − (1/2)E[|ω̂(X) − ω(X)|]. This is not an exact guarantee—it is marginal coverage degraded by density ratio estimation error. The "exact" characterization holds only in the idealized scenario where ω̂ = ω, which never occurs in practice. The paper creates a false dichotomy by criticizing prior PAC-type work as "approximate" while presenting what is itself an approximate guarantee with a different error source. The contribution statement partially acknowledges this ("quantify the error from weight estimation"), but the dominant framing throughout abstract, introduction, and Section 3 is "exact." This matters because the "exact vs. PAC" framing is the paper's primary rhetorical device and claimed contribution; the actual guarantee—marginal coverage up to density ratio error—is a different and arguably more useful type of approximation than PAC, but it is not "exact."

- **The "doubly robust" characterization is non-standard and the paper's explanation of it contains an error.** Standard double robustness means valid inference if **either** the propensity model **or** the outcome model is correctly specified, with the other arbitrarily wrong. In Theorem 4.2, A1 requires consistent estimation of the weight function (1/γ̂ → 1/γ), which is the "propensity" side. A2 requires: (i) a bounded density condition on T(w)|X, and (ii) a joint condition linking quantile regression error and weight estimation: lim[ε_N(X)/γ̂_N(X)] = lim[ε_N(X)/γ(X)]. This joint condition involves **both** estimators, meaning A2 does **not** allow the weight function to be arbitrarily misspecified. Moreover, the paper's own explanation reverses the logic: it states "when the weights function is inaccurate, the quantile estimation compensates through Assumption A1"—but A1 requires **accurate** weight estimation, not inaccurate. The "doubly robust" label misrepresents what Theorem 4.2 delivers. While having two sufficient conditions is valuable, calling this "doubly robust" in the standard causal inference sense is misleading.

### Minor

- **The τ optimization (Section 4.1) lacks theoretical justification.** Theorem 4.1 guarantees coverage for any **fixed** τ, but Algorithm 1 selects τ* adaptively per test point using the same calibration data. This data-dependent selection is not covered by the theorem. Empirically (Table 1), coverage appears maintained (0.958 at α=0.05, 0.914 at α=0.10), but with only 10 trials this provides limited assurance. The paper should acknowledge this gap explicitly; a formal argument (e.g., that since coverage holds for all τ, the maximum LPB also satisfies coverage) or a negative result would strengthen the contribution.

- **Calibration on uncensored observations only creates a practical limitation under heavy censoring.** The calibration set I^(w)_cal includes only observations with e_i = 1 (Algorithm 1, Step 3). In settings with 50–70% censoring (common in cancer clinical trials), the effective calibration sample shrinks substantially. Setting 6 (80% censoring) shows slight undercoverage, which may be an instance of this problem. The Discussion briefly mentions high censoring rates as a concern but provides no systematic analysis of how coverage and LPB width degrade with increasing censoring.

- **The simulation uses only 10 independent trials.** For a paper centered on coverage guarantees, the statistical precision of empirical coverage estimates matters. With 10 trials, the standard error on a coverage estimate of 0.90 is approximately 0.03√(0.9×0.1/10) per trial, making it difficult to distinguish 88% from 90% coverage reliably.

- **Real data coverage cannot be verified.** On the lung cancer dataset, the paper validates that LPBs correlate with known prognostic factors (Figure 4–5), which is a reasonable sanity check, but states the results "demonstrate the validity" of the LPBs (Section 5.2, final paragraph). This overstates what the analysis shows; the paper should clearly state that coverage cannot be directly validated on censored real data.

### Trivial
None.

## Nice-to-Haves

- A simulation systematically varying censoring rates would reveal the practical operating range and help practitioners decide when the method is applicable.
- A comparison of coverage with ω known vs. estimated would directly quantify the gap between the "exact" ideal and the practical guarantee.
- Incorporating censored observations into calibration (e.g., via IPCW-adjusted non-conformity scores) could mitigate the sample size penalty under heavy censoring.
- The paper should explicitly state that step (iii) of equation (1) relies on the stochastic ordering property T⊥C|X ⟹ T|e=1,X ≼_st T|X, rather than presenting it as a bare inequality.

## Removed Points

These points are flagged to be removed, treat them with caution.

- **Harsh Critic's claim that the PAC-vs-exact dichotomy is entirely false.** While the "exact" label is indeed overclaimed, the distinction between marginal and PAC-type guarantees IS meaningful: marginal coverage averages over the entire population unconditionally, while PAC-type provides coverage with high probability over calibration data. The paper's error term (density ratio estimation) is a different and more controllable type of approximation than the PAC-type error. The characterization is misleading but not entirely false—removed from Fatal, repositioned as Major with appropriate nuance.

- **Harsh Critic's claim about missing proof of the stochastic ordering at step (iii).** This is a known result under conditional independence (T⊥C|X), well-established in the length-biased sampling literature. While the paper could state it more explicitly, this is a minor presentation point, not a substantive gap.

- **Strength Finder's claim of "exact marginal coverage guarantee."** This directly conflicts with the verified Major weakness that Theorem 4.1 includes an error term. Moved to Removed Points.

- **Strength Finder's claim of "doubly robust property ensuring valid coverage under model misspecification."** This conflicts with the verified Major weakness that the double robustness is non-standard. A2 involves joint conditions on both estimators, not the standard "either one suffices with the other arbitrarily wrong." Moved to Removed Points.

- **Strength Finder's claim that "LPB optimization over τ yielding informative predictions" is a strength.** While empirically useful, the τ optimization lacks theoretical justification (verified Minor weakness), so calling it a standalone strength is misleading. Demoted to Nice-to-Have.

- **Harsh Critic's request for confidence intervals on simulation results.** While 10 trials is indeed few, demanding formal confidence intervals for conformal prediction simulation studies is not standard practice in this community; most such papers report similar trial counts. This is a Nice-to-Have rather than a weakness.

- **Harsh Critic's claim that "PAC guarantees do provide population-level guarantees with high probability."** While technically true, this misses the practical point that PAC guarantees allow a small probability of catastrophic failure (coverage much below target), which is concerning in clinical settings. The paper's point about marginal coverage being safer is valid even if imprecisely stated.

## Novel Insights

The paper reveals an interesting structural asymmetry in how estimation errors propagate in conformal prediction under distribution shift: in standard weighted conformal prediction, the coverage error depends linearly on the L1 error of the density ratio estimate (via the TV distance bound), which is a fundamentally different—and arguably more transparent—error characterization than the PAC-type approximation used by prior survival conformal methods. However, this distinction is obscured by the "exact" framing; the paper would be stronger if it honestly compared the two error types (density ratio error vs. empirical approximation error) directly, rather than claiming one is "exact" and the other "approximate."

## Suggestions

- Rewrite the abstract and introduction to frame the guarantee as "marginal coverage with an error term controlled by density ratio estimation quality" rather than "exact marginal coverage." The distinction from PAC-type guarantees remains meaningful even with honest framing.
- Fix the erroneous explanation of the doubly robust mechanism (Section 4.2, paragraph before Theorem 4.2): A1 requires accurate weight estimation, not inaccurate; the current text reverses the logic.
- Add a brief discussion of the τ optimization's theoretical status, acknowledging that Theorem 4.1 covers fixed τ and that the adaptive selection is supported empirically but not theoretically.
- Add a simulation varying censoring rates systematically to delineate the method's practical operating range.

## Score and Decision

**Calibration anchors used:**

| Paper | Path | Avg Score | Comparison |
|-------|------|-----------|------------|
| DFT-cQRF (conformal survival, overclaimed coverage) | aMXVp1QK2Q | 2.50 | Much weaker: fundamental novelty issues + overclaimed coverage for restricted subpopulation only |
| CONFEX (CP + counterfactual, overclaimed) | FE3FVddJaT | 4.00 | Weaker: incremental novelty, restrictive model scope |
| Weight Clipping for Robust CP | OPZ2f3MnrQ | 4.50 | Comparable weakness pattern (overclaimed guarantees, strong assumptions), but paper under review has more genuine technical contribution |
| CoFact (CP with reweighting, asymptotic guarantees) | eiBp7rsc3K | 5.50 | Similar pattern (reweighting + asymptotic guarantees), but paper under review has a more novel reweighting insight |
| CP with Corrupted Labels (reweighting + triply robust) | ztEKLEUNKS | 6.00 | Stronger: cleaner theoretical framing, less overclaiming, better-established robustness |
| Minimax-Optimal DRE | gDxJK8yvZU | 7.50 | Much stronger: clean theoretical contribution, minimax-optimal guarantees, no overclaiming |

The paper under review has a genuine and non-trivial technical contribution (the reweighting scheme in equation 1), but the overclaiming of "exact" coverage when Theorem 4.1 itself shows an error term, and the non-standard "doubly robust" characterization, significantly undermine the paper's own framing of its contribution. Compared to CoFact (5.50) which has a similar reweighting+asymptotic pattern but less overclaiming, and CP with Corrupted Labels (6.00) which has cleaner theory, this paper falls between them due to its more severe overclaiming offsetting its more novel core insight.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>